{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:36:08Z","timestamp":1784259368551,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.rdc.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:18:29Z","timestamp":1424996309000},"page":"315-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pulmonary Vasculitis"],"prefix":"10.1016","volume":"41","author":[{"given":"Lindsay","family":"Lally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Spiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2015.01.004_bib1","first-page":"413","article-title":"Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis","volume":"109","author":"Mark","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccm.2004.04.007","article-title":"Diffuse alveolar hemorrhage","volume":"25","author":"Collard","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00075309","article-title":"Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality","volume":"35","author":"de Prost","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2015.01.004_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.iac.2012.08.001","article-title":"Update on diffuse alveolar hemorrhage and pulmonary vasculitis","volume":"32","author":"Krause","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.rdc.2015.01.004_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1148\/radiol.10090105","article-title":"Imaging of pulmonary vasculitis","volume":"255","author":"Chung","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.rdc.2015.01.004_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.clinimag.2012.11.005","article-title":"Diffuse alveolar hemorrhage in patients with hematological malignancies: HRCT patterns of pulmonary involvement and disease course","volume":"37","author":"Spira","year":"2013","journal-title":"Clin Imaging"},{"key":"10.1016\/j.rdc.2015.01.004_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib8","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1183\/09031936.97.10122738","article-title":"Efficacy of transbronchial biopsy in pulmonary vasculitides","volume":"10","author":"Schnabel","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2015.01.004_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00000478-199012000-00003","article-title":"A\u00a0clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation","volume":"14","author":"Travis","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2015.01.004_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-012-9431-7","article-title":"Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review","volume":"191","author":"von Ranke","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.rdc.2015.01.004_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1843.2008.01444.x","article-title":"Aetiologies and outcomes of diffuse alveolar haemorrhage presenting as acute respiratory failure of uncertain cause","volume":"14","author":"Jin","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2015.01.004_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00408-013-9491-3","article-title":"Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale","volume":"191","author":"de Prost","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.rdc.2015.01.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2015.01.004_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjmed.2006.08.016","article-title":"ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis","volume":"120","author":"Finkielman","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies in the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2169\/internalmedicine.52.8863","article-title":"Diffuse alveolar haemorrhage in ANCA-associated vasculitis","volume":"52","author":"West","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener\u2019s granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2172-15-20","article-title":"Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis","volume":"15","author":"Hassan","year":"2014","journal-title":"BMC Immunol"},{"key":"10.1016\/j.rdc.2015.01.004_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00005792-200007000-00003","article-title":"Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP)","volume":"79","author":"Lauque","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2015.01.004_bib22","first-page":"S77","article-title":"Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors","volume":"30","author":"Kostianovsky","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ppul.22793","article-title":"Lung manifestations in MPO-ANCA associated vasculitides in children","volume":"49","author":"Ben Ameur","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rdc.2015.01.004_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/RHU.0b013e3181b59581","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases","volume":"15","author":"Lin","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2013.08.025","article-title":"Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis","volume":"63","author":"Ford","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.rdc.2015.01.004_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MAJ.0b013e31816805fa","article-title":"Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis","volume":"336","author":"Holguin","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rdc.2015.01.004_bib27","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.01.004_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-9-33","article-title":"Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report","volume":"9","author":"Baird","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.rdc.2015.01.004_bib34","first-page":"37","article-title":"Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm","volume":"6","author":"Heslet","year":"2012","journal-title":"Biologics"},{"key":"10.1016\/j.rdc.2015.01.004_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rmr.2010.07.007","article-title":"Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage","volume":"28","author":"Dabar","year":"2011","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rdc.2015.01.004_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.rdc.2015.01.004_bib37","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2015.01.004_bib38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.rdc.2015.01.004_bib40","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib41","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/art.34547","article-title":"Brief report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"34","author":"Faurschou","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A\u00a0randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib43","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib44","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2015.01.004_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib46","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.34583","article-title":"Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Smith","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2014.03.002","article-title":"Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegeners). Results of a single-center cohort study on 66 patients","volume":"50","author":"Calich","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2015.01.004_bib48","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener\u2019s): a single-center ten-year experience","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib50","unstructured":"Available at: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6104a9.htm. Accessed November 20, 2014."},{"key":"10.1016\/j.rdc.2015.01.004_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rdc.2015.01.004_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0961203309360545","article-title":"Non-criteria manifestations of antiphospholipid syndrome","volume":"19","author":"Erkan","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2015.01.004_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/096120339600500506","article-title":"Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort","volume":"5","author":"Lie","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2015.01.004_bib54","first-page":"805","article-title":"Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment","volume":"26","author":"Gertner","year":"1999","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semarthrit.2005.08.006","article-title":"Diffuse alveolar hemorrhage: a nonthrombotic antiphospholipid lung syndrome?","volume":"35","author":"Asherson","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/acr.22109","article-title":"Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage","volume":"66","author":"Cartin-Ceba","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2015.01.004_bib58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semarthrit.2005.05.006","article-title":"Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review","volume":"35","author":"Deane","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2014.01.024","article-title":"Diagnosis and classification of Goodpasture's disease (anti-GBM)","volume":"49","author":"Hellmark","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2015.01.004_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib61","first-page":"249","article-title":"Anti-GBM disease: predictive value of clinical, histological and serological data","volume":"40","author":"Herody","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.rdc.2015.01.004_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/md.0b013e318067da56","article-title":"Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases","volume":"86","author":"Lazor","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2015.01.004_bib63","first-page":"372","article-title":"Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases","volume":"9","author":"Merkel","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rdc.2015.01.004_bib64","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/oxfordjournals.ndt.a027154","article-title":"Goodpasture's syndrome with normal renal function","volume":"11","author":"Min","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rdc.2015.01.004_bib65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.autrev.2014.02.007","article-title":"Rapidly progressive crescentic glomerulonephritis: early treatment is a must","volume":"13","author":"Moroni","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2015.01.004_bib67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","article-title":"Goodpasture's disease: a report of ten cases and a review of the literature","volume":"12","author":"Dammacco","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2015.01.004_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000334155","article-title":"Plasmapheresis in immunologic renal disease","volume":"33","author":"Pusey","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.rdc.2015.01.004_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9343(78)90065-7","article-title":"Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture\u2019s syndrome","volume":"64","author":"Johnson","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.semarthrit.2012.10.007","article-title":"Anti-glomerular basement membrane antibody disease treated with rituximab: a case-based review","volume":"42","author":"Syeda","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib71","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10067-013-2268-5","article-title":"Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody","volume":"32","author":"Srivastava","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2015.01.004_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rdc.2015.01.004_bib74","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","article-title":"Pulmonary artery aneurysms in Beh\u00e7et syndrome","volume":"117","author":"Hamuryudan","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","article-title":"Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease: a series of 47 patients","volume":"91","author":"Seyahi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2015.01.004_bib76","first-page":"147","article-title":"Pulmonary artery aneurysms in Beh\u00e7et's disease: contribution of imaging in 5 cases","volume":"153","author":"Hassine","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.rdc.2015.01.004_bib77","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10067-006-0408-x","article-title":"Multislice CT pulmonary findings in Beh\u00e7et's disease (report of 16 cases)","volume":"26","author":"Emad","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jbspin.2012.11.003","article-title":"18F-fluorodeoxyglucose-positron emission tomography scanning is a useful tool for therapy evaluation of arterial aneurysm in Beh\u00e7et's disease","volume":"80","author":"Trad","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2015.01.004_bib79","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1378\/chest.127.6.2243","article-title":"Pulmonary vasculitis in Behcet disease: a cumulative analysis","volume":"127","author":"Uzun","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2015.01.004_bib80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.rdc.2013.02.010","article-title":"Beh\u00e7et's syndrome","volume":"39","author":"Hatemi","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2015.01.004_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3182428126","article-title":"Long-term outcome of arterial lesions in Beh\u00e7et disease: a series of 101 patients","volume":"91","author":"Saadoun","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2015.01.004_bib82","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2011.02.006","article-title":"Resolution of Beh\u00e7et's syndrome associated pulmonary arterial aneurysms with infliximab","volume":"41","author":"Schreiber","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1024\/0301-1526.32.3.149","article-title":"Surgical treatment of vasculo-Beh\u00e7et's disease. A review of patients with concomitant multiple aneurysms and venous lesions","volume":"32","author":"Ceyran","year":"2003","journal-title":"Vasa"},{"key":"10.1016\/j.rdc.2015.01.004_bib84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jvs.2005.05.057","article-title":"The surgical treatment of arterial aneurysms in Beh\u00e7et disease: a report of 16 patients","volume":"42","author":"Kalko","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.rdc.2015.01.004_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9260(05)81929-4","article-title":"The incidence and patterns of pulmonary artery involvement in Takayasu's arteritis","volume":"42","author":"Sharma","year":"1990","journal-title":"Clin Radiol"},{"key":"10.1016\/j.rdc.2015.01.004_bib86","first-page":"S48","article-title":"Respiratory system involvement in systemic vasculitides","volume":"24","author":"Manganelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib87","first-page":"469","article-title":"Isolated pulmonary Takayasu arteritis: clinicopathologic characteristics","volume":"9","author":"Lie","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.rdc.2015.01.004_bib88","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.semarthrit.2011.06.001","article-title":"Pulmonary arteries involvement in Takayasu's arteritis: two cases and literature review","volume":"41","author":"Toledano","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib89","first-page":"215","article-title":"Non-invasive assessment of pulmonary artery involvement in Takayasu's arteritis","volume":"17","author":"Vanoli","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib90","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.24416","article-title":"Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?","volume":"60","author":"Arnaud","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2015.01.004_bib91","first-page":"S3","article-title":"Pulmonary artery involvement in Takayasu arteritis. PET\/CT versus CT angiography","volume":"31","author":"Addimanda","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib92","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2015.01.004_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0000000000000004","article-title":"Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies","volume":"26","author":"Clifford","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2015.01.004_bib94","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/clc.20665","article-title":"Percutaneous transluminal angioplasty and stenting for pulmonary stenosis due to Takayasu's arteritis: clinical outcome and four-year follow-up","volume":"32","author":"Qin","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.rdc.2015.01.004_bib95","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11748-012-0019-1","article-title":"Pulmonary artery replacement for pulmonary Takayasu's arteritis","volume":"60","author":"Hamamoto","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:53Z","timestamp":1760181233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X15000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0889857X15000058"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.01.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}